DELTEX

Pharmaceuticals in the nature of cell therapeutics for the treatment and prevention of cancer; engineered cell therapies, namely, engineered T cells, immune cells, and antibodies for the treatment and prevention of cancer

Medical research and development; Research and development of pharmaceuticals; Research and development in the field of bioengineering and genetic engineering; Research and development of treatments and therapies in the field of oncology; Research and development of pharmaceuticals for the treatment and prevention of cancer, autoimmune, inflammatory, and infectious diseases and disorders; Scientific research for medical purposes in the field of cancer, autoimmune, inflammatory, and infectious diseases and disorders; Molecular, cellular, and genetic research and development; Development of processes and methods for the manufacturing and engineering of cells and molecules; development of therapeutics and treatments for the prevention of cancer, autoimmune, inflammatory, genetic and infectious diseases and disorders

Medical services; Providing health information; Providing health information in the field of bioengineering and genetic engineering; Providing health information in the field of autoimmune, inflammatory and infectious diseases and disorders, cancer prevention and treatment; Medical diagnosis and treatment of cancer, autoimmune, inflammatory, and infectious diseases and disorders